RIDGEFIELD, Conn., Nov. 2, 2015 /PRNewswire/ -- Boehringer Ingelheim announced today that it has been recognized by Science magazine for the eleventh consecutive year as a top company to work for in the pharmaceutical and biotechnology industry. Boehringer Ingelheim was listed among 20 companies, demonstrating its strong reputation.
"As a company focused on advancing science, we are committed to creating a culture that engages employees and inspires innovative thinking from research to developing partnerships," said Dr. Paige Mahaney, head, Research and Small Molecule Discovery, U.S., Boehringer Ingelheim Pharmaceuticals, Inc. "We understand the importance of fostering strong relationships with our employees, who are at the core of our company and play a critical role in bringing new medicines to patients. Being named to Science magazine's Top Employer list for the eleventh time is an honor and a testament to our efforts."
In Science magazine's annual survey, respondents were asked to rate companies based on 23 characteristics, including corporate image, financial prowess, leadership and direction, work culture/environment, location, and academic and intellectual challenge. Unique ranking scores were then derived from the ratings given to each company on these attributes. The top 20 companies with the best reputations as employers were culled from a list of more than 180 companies.
For the feature story on the survey, along with individual company rankings, visit www.sciencecareers.org/TopEmployers2015.
The latest of workplace awards, this recognition follows the recent news that Boehringer Ingelheim was named to Working Mother's 100 Best Companies list.
About Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation.
Boehringer Ingelheim is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, the company operates globally with 146 affiliates and more than 47,000 employees. Since its founding in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel treatments for human and veterinary medicine.
Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and families. Our employees create and engage in programs that strengthen our communities. To learn more about how we make more health for more people, visit our Corporate Social Responsibility Report.
In 2014, Boehringer Ingelheim achieved net sales of about $16.96 billion dollars (13.3 billion euros). R&D expenditure corresponds to 19.9 percent of its net sales.
SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.